Regional Analysis

Global Cell Surface Markers Detection Market: Regional Insights

Based on geography, the global cell surface markers detection market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period due to the increasing prevalence of cancer, rise in use of cell surface markers in diagnostics, and technological advancements in the region. For instance, a paradigm shift in healthcare from disease diagnosis to risk assessment or early diagnosis has increased the use of biomarkers in drug development. According to the American Cancer Society (ACS), cancer continues to be the second most common cause of death in the U.S., after heart disease. In 2023, a total of 1.9 million new cancer cases (about 5,370 cases each day) and 609,820 deaths from cancer are expected to occur (about 1,670 deaths a day) in the United States.

Asia Pacific is also expected to witness robust growth in the global cell surface markers detection market due to the rise in burden of cancer, increase in funding for life science research, and rise in demand for precision medicine in the region. For instance, according to the cancer report by Indian Council of Medical Research (ICMR), India’s cancer cases could increase by 12% in the next five years (2020-2023), with 1.5 million people projected to suffer from the non-communicable disease by 2025, up from 1.39 million in 2020. This in turn is expected to aid in the growth of the global cell surface markers detection market in the region.

North America: U.S. and Canada
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Middle East & Africa: GCC Countries, Israel, and Rest of Middle East and South Africa, North Africa, and Central Africa